Capital Squared Financial’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$345K Buy
288
+5
+2% +$5.11K 0.23% 68
2026
Q1
$261K Buy
283
+62
+28% +$62.9K 0.2% 75
2025
Q4
$237K Buy
+221
New +$211K 0.19% 77

Other funds holding LLY

Capital Squared Financial's LLY Position: Q2 2026 in Review

Capital Squared Financial increased its Eli Lilly (LLY) stake by 1.8% in Q2 2026, buying an estimated $5.11K and bringing the position to 288 shares worth $345K. The position accounts for 0.23% of the portfolio, ranked #68.

Capital Squared Financial first reported a position in LLY in Q4 2025 and has held it in 3 quarters since. 1,453 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Capital Squared Financial held 288 shares of Eli Lilly worth $345K as of Q2 2026.
  • Capital Squared Financial bought 5 Eli Lilly shares in Q2 2026, an estimated $5.11K.
  • Eli Lilly made up 0.23% of Capital Squared Financial's portfolio in Q2 2026, its #68 holding.
  • Capital Squared Financial first reported a position in Eli Lilly in Q4 2025 and has held it in 3 quarters since.
  • 1,453 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Capital Squared Financial's 13F filing for Q2 2026, filed 22 Jul 2026.